122 related articles for article (PubMed ID: 29468578)
1. Does MCDA Trump CEA?
Campillo-Artero C; Puig-Junoy J; Culyer AJ
Appl Health Econ Health Policy; 2018 Apr; 16(2):147-151. PubMed ID: 29468578
[No Abstract] [Full Text] [Related]
2. The Use of MCDA in HTA: Great Potential, but More Effort Needed.
Marsh KD; Sculpher M; Caro JJ; Tervonen T
Value Health; 2018 Apr; 21(4):394-397. PubMed ID: 29680094
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation approaches for new technology.
Papatheofanis FJ
IEEE Eng Med Biol Mag; 2003; 22(3):16-7. PubMed ID: 12845811
[No Abstract] [Full Text] [Related]
4. Multiple criteria decision analysis for health technology assessment.
Thokala P; Duenas A
Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
[TBL] [Abstract][Full Text] [Related]
5. Comment on: "Does MCDA Trump CEA?".
Angelis A; Kanavos P
Appl Health Econ Health Policy; 2019 Feb; 17(1):123-124. PubMed ID: 30467732
[No Abstract] [Full Text] [Related]
6. Authors' Reply to Angelis and Kanavos: "Does MCDA Trump CEA?".
Campillo-Artero C; Puig-Junoy J; Culyer AJ
Appl Health Econ Health Policy; 2019 Feb; 17(1):125. PubMed ID: 30460622
[No Abstract] [Full Text] [Related]
7. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N;
Value Health; 2016; 19(2):125-37. PubMed ID: 27021745
[TBL] [Abstract][Full Text] [Related]
8. Treacle and Smallpox: Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment.
Morton A
Value Health; 2017 Mar; 20(3):512-515. PubMed ID: 28292498
[TBL] [Abstract][Full Text] [Related]
9. International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review.
Lasalvia P; Prieto-Pinto L; Moreno M; Castrillón J; Romano G; Garzón-Orjuela N; Rosselli D
Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):409-420. PubMed ID: 31210065
[No Abstract] [Full Text] [Related]
10. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
11. Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.
Thokala P; Devlin N; Marsh K; Baltussen R; Boysen M; Kalo Z; Longrenn T; Mussen F; Peacock S; Watkins J; Ijzerman M
Value Health; 2016 Jan; 19(1):1-13. PubMed ID: 26797229
[TBL] [Abstract][Full Text] [Related]
12. Could or Should We Use MCDA in the French HTA Process?
Ghabri S; Josselin JM; Le Maux B
Pharmacoeconomics; 2019 Dec; 37(12):1417-1419. PubMed ID: 31565761
[No Abstract] [Full Text] [Related]
13. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
[TBL] [Abstract][Full Text] [Related]
14. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
[TBL] [Abstract][Full Text] [Related]
15. Update on technology assessment in dentistry.
Antczak-Bouckoms A; Tulloch JF
Curr Opin Dent; 1992 Jun; 2():10-4. PubMed ID: 1387819
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based decision making in healthcare in Central Eastern Europe.
Ferrario A; Baltezarević D; Novakovic T; Parker M; Samardzic J
Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):611-5. PubMed ID: 25090222
[No Abstract] [Full Text] [Related]
17. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
[TBL] [Abstract][Full Text] [Related]
18. [Health-care costs and health technology assessment].
Lettieri E; Masella C
G Ital Nefrol; 2007; 24 Suppl 40():s22-36. PubMed ID: 18034409
[TBL] [Abstract][Full Text] [Related]
19. Health Technology Assessment and Appraisal of Therapies for Rare Diseases.
Iskrov G; Miteva-Katrandzhieva T; Stefanov R
Adv Exp Med Biol; 2017; 1031():221-231. PubMed ID: 29214575
[TBL] [Abstract][Full Text] [Related]
20. Expanding Health Technology Assessments to Include Effects on the Environment.
Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
